Write in a clean editor, then format for Mental Health Weekly in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Mental Health Weekly is a peer-reviewed journal published by Wiley, covering Mental Health Treatment and Access, Suicide and Self-Harm Studies, Psychiatric care and mental health services.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Mental Health Weekly 12 (3): 45–58.
Formats any DOI in Mental Health Weekly style. No sign-up. |
| Publishes research in | Mental Health Treatment and Access Suicide and Self-Harm Studies Psychiatric care and mental health services Digital Mental Health Interventions Mental Health and Patient Involvement |
| ISSN | 1058-1103 |
| Citation impact (2-yr) | 0.02 |
| h-index | 11 |
| i10-index | 14 |
| Total citations | 838 |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Increased mental health disorders, prolonged isolation, hospital bed adequacy, lost revenue and staff safety are among the myriad of concerns the field is dealing with in the wake of the COVID‐19 epidemic. And for some staff, protective gear is in order.
For the first time, the Food and Drug Administration (FDA) on June 15 approved a prescription treatment delivered through a video game for children with attention deficit hyperactivity disorder (ADHD). The digital therapy device offers a nondrug option for improving symptoms associated with ADHD in children.
The Food and Drug Administration (FDA) announced Aug. 3 approval of Janssen Pharmaceutical's supplemental new drug application (sNDA) for the expanded use of SPRAVATO esketamine Clll nasal spray for the treatment of major depressive disorder (MDD) with acute suicidal ideation or behavior. SPRAVATO was initially approved by the FDA March 5, 2019, for the treatment…
Nearly half of Americans (48%) are anxious about the possibility of getting COVID‐19, and nearly four in 10 Americans (40%) are anxious about becoming seriously ill or dying from it, according to a new national poll released by the American Psychiatric Association (APA) March 15. However, many more Americans (62%) are anxious about the possibility…
COVID‐19 is undoubtedly placing a considerable toll on parents, according to the American Psychological Association's (APA's) annual Stress in America report, with many saying that working from home while coordinating their children's online learning is causing a significant amount of stress. To better understand how individuals are coping with the extreme stress of this crisis,…
